This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Pregnancy-Safe Skin Care Guidelines: Expert Consensus Recommendations

Sponsored by Venus Research Center

About this trial

Last updated 6 months ago

Study ID

Pregnancy-Safe Skin Care-Venus

Status

Enrolling by invitation

Type

Observational

Placebo

No

Accepting

25+ Years
All Sexes

Trial Timing

Started 5 months ago

What is this trial about?

This research presents a comprehensive consensus on pregnancy skin care, synthesizing expert recommendations to ensure maternal skin health while prioritizing fetal safety. It outlines safe and effective skin care practices tailored to the physiological and hormonal changes during pregnancy. Key guidelines emphasize the use of gentle cleansing, adequate hydration, mineral-based sun protection, and the selection of dermatologically safe ingredients such as vitamin C, hyaluronic acid, niacinamide, and azelaic acid. The consensus highlights the avoidance of potentially harmful substances including retinoids, high-dose salicylic acid, and certain chemical sunscreens. Additionally, the research provides clinical guidance on managing common pregnancy-related skin conditions and cautions against aggressive cosmetic procedures. The outcomes serve as a critical resource for dermatologists and healthcare providers to optimize skin care regimens during pregnancy, balancing efficacy with safety for both mother and child.

What are the participation requirements?

Inclusion Criteria

* Board-certified dermatologist or plastic surgeon OR physician practicing aesthetic medicine. * Minimum of 5 years of clinical experience. * Practicing within Egypt or the Middle East and North Africa (MENA) region. * Willingness to participate in Delphi rounds and provide expert ratings. * Ability to read and respond to surveys in English.

Exclusion Criteria

Inability or unwillingness to complete Delphi rounds. * Lack of clinical experience with Pregnant ladies. * Industry representatives without direct clinical practice.